KRAS and non-small cell lung carcinoma: Targeting the downstream target of KRAS signaling, mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) in KRAS-mutated NSCLC has been reported to be largely ineffective [133, 134].